Díaz-Díaz, J., Ramirez, C. I., Ortiz-Pica, M., García-Yusta, E., Gómez-Estevez, I., & Oreja-Guevara, C. (2021). Is natalizumab a safe treatment for patients with multiple sclerosis in the COVID-19 pandemic? Data from the first year of the pandemic. Mult Scler Relat Disord.
Styl ChicagoDíaz-Díaz, Judit, Clara Isabel Ramirez, Marta Ortiz-Pica, Elena García-Yusta, Irene Gómez-Estevez, a Celia Oreja-Guevara. "Is Natalizumab a Safe Treatment for Patients With Multiple Sclerosis in the COVID-19 Pandemic? Data From the First Year of the Pandemic." Mult Scler Relat Disord 2021.
Citace podle MLADíaz-Díaz, Judit, et al. "Is Natalizumab a Safe Treatment for Patients With Multiple Sclerosis in the COVID-19 Pandemic? Data From the First Year of the Pandemic." Mult Scler Relat Disord 2021.